Patents by Inventor Inna SHOMER

Inna SHOMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230095010
    Abstract: The invention provides a method for treating cancer comprising the step of administering a therapeutically effective amount of KPC1, a peptide which is at least about 70% homologous to the KPC1 or an agent which up-regulates KPC1. In some embodiments, there is also provided a method for treating cancer comprising the step of administering a therapeutically effective amount of p50, a peptide which is at least about 70% homologous to the p50 or an agent which up-regulates p50.
    Type: Application
    Filed: August 15, 2022
    Publication date: March 30, 2023
    Applicant: Technion Research & Development Foundation Limited.
    Inventors: Aaron CIECHANOVER, Yelena KRAVTSOVA, Inna SHOMER, Victoria COHEN
  • Patent number: 11452759
    Abstract: The invention provides a method for treating cancer comprising the step of administering a therapeutically effective amount of KPC1, a peptide which is at least about 70% homologous to the KPC1 or an agent which up-regulates KPC1. In some embodiments, there is also provided a method for treating cancer comprising the step of administering a therapeutically effective amount of p50, a peptide which is at least about 70% homologous to the p50 or an agent which up-regulates p50.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: September 27, 2022
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Aaron Ciechanover, Yelena Kravtsova, Inna Shomer, Victoria Cohen
  • Publication number: 20180140667
    Abstract: The invention provides a method for treating cancer comprising the step of administering a therapeutically effective amount of KPC1, a peptide which is at least about 70% homologous to the KPC1 or an agent which up-regulates KPC1. In some embodiments, there is also provided a method for treating cancer comprising the step of administering a therapeutically effective amount of p50, a peptide which is at least about 70% homologous to the p50 or an agent which up-regulates p50.
    Type: Application
    Filed: January 5, 2016
    Publication date: May 24, 2018
    Applicant: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
    Inventors: Aaron CIECHANOVER, Yevgenia KRAVCHENKO, Inna SHOMER, Victoria COHEN